<DOC>
	<DOCNO>NCT01799850</DOCNO>
	<brief_summary>Subjects type 2 diabetes treat Actos placebo eight week needle biopsy muscle quantify change seven different glucose transport protein muscle .</brief_summary>
	<brief_title>The Impact Actos Treatment Diabetes Glucose Transporters Muscle</brief_title>
	<detailed_description>Twelve subject type 2 diabetes , fair control oral medication , recruit participate randomize , double-blind , placebo-controlled study impact muscle glucose transporter expression addition insulin-sensitizing agent , pioglitizone ( Takeda Pharmaceuticals ) . Therapy active drug 30 mg daily . The oral medication adjust downward hypoglycemia occur . Glycemic control monitor least twice daily home blood glucose monitoring , weekly telephone contact , follow-up visit ETSU/VAMC Clinical Research Unit ( CRU ) every two week . During eight week therapy , subject instruct maintain weight keep dietary exercise regimen unchanged . Muscle biopsy obtain end eight week therapy . Specimens assay GLUT1 , GLUT3 , GLUT4 , GLUT5 , GLUT8 , GLUT11 , GLUT12 mRNA protein content subcellular distribution protein describe . Peroxisome proliferator-activated receptor gamma ( PPARgamma ) , member ligand-activated nuclear hormone receptor superfamily ( 14 ) , quantify specimen immunoblot describe . This study design involve randomize , double-blinded , placebo-controlled treatment regimen need control confound variable cause change glucose transporter expression may erroneously attribute drug . These potential variable include close contact diabetes management team result improve compliance diet , exercise , medication , monitor thus well glycemic control , weight loss , improved fitness .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>diabetes , type 2 HbA1c less 8.5 insulin therapy renal insufficiency clinically apparent coronary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>muscle</keyword>
	<keyword>glucose transporter</keyword>
	<keyword>GLUT4</keyword>
	<keyword>GLUT5</keyword>
	<keyword>Actos</keyword>
</DOC>